𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Computed tomography of sclerosing hepatocellular carcinoma

✍ Scribed by Junichi Yoshida; Tadatoshi Takayama; Junji Yamamoto; Kazuaki Shimada; Tomoo Kosuge; Susumu Yamasaki; Hiroshi Hasegawa; Noriyuki Moriyama; Kenichi Takayasu; Yukio Muramatsu; Michiie Sakamoto; Setsuo Hirohashi; Masatoshi Makuuchi

Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
713 KB
Volume
16
Category
Article
ISSN
0895-6111

No coin nor oath required. For personal study only.

✦ Synopsis

We reviewed computed tomography (CT) in eight patients with sclerosing hepatocellular carcinoma who underwent resection. Dynamic CT was performed 25-40 s (rapid phase) and 5-10 min (late phase) after injection of contrast medium. Most of the lesions were round and homogeneous. Tumors tended to show density equal to the liver. The relative density of the tumors in the rapid phase, however, tended to be higher than in other phases. A peripheral low-density area was absent. Dynamic CT was thus important in the diagnosis of sclerosing hepatocellular carcinoma.

πŸ“œ SIMILAR VOLUMES

Recurrent hepatocellular carcinoma: Usef
Recurrent hepatocellular carcinoma: Usefulness of ultrasonography compared with computed tomography and AFP assay
✍ Toshiya Shibata; Souichi Kubo; Kyo Itoh; Tadashi Sagoh; Kazumasa Nishimura; Yosh πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 723 KB

Follow-up studies using monitoring with alpha,-feto protein (AFP), ultrasonography (US), and computed tomography (CT) were carried out in 75 patients who had prior partial hepatectomy for hepatocellular carcinoma (HCC). Recurrence in the remaining liver was confirmed in 31 patients (41.3%) during th

Usefulness 18F-FDG positron emission tom
Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients
✍ Young-Kyu Kim; Kwang-Woong Lee; Seong Yeon Cho; Sung-Sik Han; Seong Hoon Kim; Se πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 91 KB

18 F-fluoro-2-deoxy-D-glucose ( 18 F-FDG) positron emission tomography (PET)/computed tomography (CT) has recently been shown to be able to predict a poor outcome after liver transplantation (LT) for patients with hepatocellular carcinoma (HCC). However, there are few reports on the usefulness of PE